Infimer (Israel) Odds of Future Stock Price Finishing Over 6020.0
| INFR Stock | ILA 20,890 15,890 317.80% |
Infimer |
Infimer Target Price Odds to finish over 6020.0
The tendency of Infimer Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above 6,020 in 90 days |
| 20,890 | 90 days | 6,020 | about 62.26 |
Based on a normal probability distribution, the odds of Infimer to stay above 6,020 in 90 days from now is about 62.26 (This Infimer probability density function shows the probability of Infimer Stock to fall within a particular range of prices over 90 days) . Probability of Infimer price to stay between 6,020 and its current price of 20890.0 at the end of the 90-day period is about 48.5 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 95.0 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Infimer will likely underperform. In addition to that Infimer has an alpha of 69190.7621, implying that it can generate a 69190.76 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Infimer Price Density |
| Price |
Predictive Modules for Infimer
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Infimer. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Infimer Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Infimer is not an exception. The market had few large corrections towards the Infimer's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Infimer, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Infimer within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 69,191 | |
β | Beta against Dow Jones | 95.00 | |
σ | Overall volatility | 10,594 | |
Ir | Information ratio | 0.21 |
Infimer Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Infimer for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Infimer can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Infimer is way too risky over 90 days horizon | |
| Infimer appears to be risky and price may revert if volatility continues | |
| Infimer has accumulated 289 K in total debt. Infimer has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Infimer until it has trouble settling it off, either with new capital or with free cash flow. So, Infimer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Infimer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Infimer to invest in growth at high rates of return. When we think about Infimer's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 378 K. Net Loss for the year was (7.99 M) with loss before overhead, payroll, taxes, and interest of (899 K). | |
| Infimer has accumulated about 14 K in cash with (1.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 14.0% of the company shares are held by company insiders |
Infimer Technical Analysis
Infimer's future price can be derived by breaking down and analyzing its technical indicators over time. Infimer Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Infimer. In general, you should focus on analyzing Infimer Stock price patterns and their correlations with different microeconomic environments and drivers.
Infimer Predictive Forecast Models
Infimer's time-series forecasting models is one of many Infimer's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Infimer's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Infimer
Checking the ongoing alerts about Infimer for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Infimer help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Infimer is way too risky over 90 days horizon | |
| Infimer appears to be risky and price may revert if volatility continues | |
| Infimer has accumulated 289 K in total debt. Infimer has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Infimer until it has trouble settling it off, either with new capital or with free cash flow. So, Infimer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Infimer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Infimer to invest in growth at high rates of return. When we think about Infimer's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 378 K. Net Loss for the year was (7.99 M) with loss before overhead, payroll, taxes, and interest of (899 K). | |
| Infimer has accumulated about 14 K in cash with (1.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 14.0% of the company shares are held by company insiders |
Other Information on Investing in Infimer Stock
Infimer financial ratios help investors to determine whether Infimer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Infimer with respect to the benefits of owning Infimer security.